EGFR and colorectal carcinoma: Anti-VEGF and EGFR antibodies could not only reduce CRC cells proliferation and invasion in vitro, but also inhibit the tumor growth and angiogenesis in vivo through inhibiting the activation of AKT and ERK signaling pathways.